A carregar...
Neoadjuvant therapy in pancreatic cancer: what is the true oncological benefit?
BACKGROUND: Neoadjuvant therapies (neoTx) have revolutionized the treatment of borderline resectable (BR) and locally advanced (LA) pancreatic cancer (PCa) by significantly increasing the rate of R0 resections, which remains the only curative strategy for these patients. However, there is still room...
Na minha lista:
| Publicado no: | Langenbecks Arch Surg |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Berlin Heidelberg
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7541356/ https://ncbi.nlm.nih.gov/pubmed/32776259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00423-020-01946-4 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|